Celgene Corp.

NAS: CELG
Pharmaceuticals
Summit NJ
Title 1Executive Chairman
Executive 1Mr. Robert J. Hugin, Executive Chairman | Executive Chairman
2015 Revenue (US$ Millions)$9,256
2014 Revenue (US$ Millions)$7,670
Revenue Growth (%)20.67%
Net Income (US$ Millions)$1,602
Common Shares Outstanding (Millions)$787
Earnings Per Share (US$)$1.94
Price To Earnings Ratio68.82
Total Equity (US$ Millions)$5,919
Return On Equity (%)24.55%
Long Term Debt (US$ Millions)$14,250
Debt To Equity Ratio (%)2.41%
Market Capitalization (US$ Millions)$94,203
Total Assets (US$ Millions)$27,053
Current Assets (US$ Millions)$9,401
Inventories (US$ Millions)$443
Current Liabilities (US$ Millions)$1,969
Cost of Goods Sold (US$ Millions)$420
Asset Turnover0.34
Inventory Turnover1